CRWEResearch.com, issued a research report on Cavitation Technologies Inc.(CVAT.OB) with a BUY recommendation of $2.00 long, $1.20 Medium and $0.80 short term target prices.
Las Vegas, NV, USA, November 10, 2009 (PRESSbooth.ORG) -- Highlights of full report written by Kenneth Bosket were:
Cavitataion Technologies Inc., executed a Letter or Intent with Womack Systems, LLC (www.womack-machine.com) for the manufacture of its cutting edge Nano-Cavitation Process Systems.
Cavitation Technology, Inc., is striving for a leading position in all its markets and business segments. This company’s reactor is a patent-pending flow-through nano-caitation technology (NCR) that represents a quantum leap over existing technologies for a wide variety of applications and industries.
Cavitataion Technologies Inc., costs substantially less than competing technologies.
Cavitataion Technologies Inc., BioForce 9000 System: CTI offers new generation equipment for producing biodiesel which utilize Flow-Through Nano -Cavitation technology
View full report at CRWESelect.com
About Cavitation Technologies:
Cavitation Technologies, Inc. (CTI); (OTC Bulletin Board: CVAT); is a "Green-Tech" company, established in 2006 to become a world leader in the development of new cutting edge technologies for the vegetable oil refining, renewable fuel, petroleum, water treatment, wastewater sanitation, food and beverage, and chemical industries. For additional information please visit:
www.cavitationtechnologies.com
About CRWENewswire.com:
CRWENewswire.com is an independent electronic informative online financial news publication company dedicated in providing company associates, business and financial professionals with economic and investment information, as well as stock highlights. CRWENewswire.com is a division of Crown Equity Holdings, Inc.
CRWENewswire.com is not a registered investment advisor or broker-dealer. CRWENewswire.com and Crown Equity Holdings, Inc., (CRWE) affiliates, officers, directors, contractors and employees, including may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has received five thousand shares of free trading stock from a third party for advertising services for Cavitation Technologies, Inc. (CVAT.OB) and an additional twenty-five thousand shares of 144 restricted stock from Cavitation Technologies, Inc. (CVAT.OB) for 12 months of advertisement services.
We encourage investors to join and receive CRWENewswire.com FREE e-mail news and stock watch alerts at
http://www.crwenewswire.com/c/stock-pr
and view our full disclaimer.
:: 
:: 
::
